Safety and Performance of the OTTAVA System in Participants Undergoing Inguinal Hernia Repair

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age22+
SponsorAuris Health, Inc.

About this trial

The purpose of this study is to assess safety and performance of the OTTAVA System, through 30 days postoperative, in participants undergoing robotic-assisted inguinal hernia repair (IHR).

Eligibility criteria

Qualifiers

Willing and able to provide informed consent

A minimum of 22 years old at time of consent

Scheduled for elective primary inguinal hernia repair

American Society of Anesthesiologists (ASA) classification I, II, or III

Disqualifiers

Physician determination, including intraoperative finding, that subject is a poor candidate for robotic surgery

Scheduled concomitant surgical procedure, other than lysis of adhesions, groin hernia repair, or umbilical or epigastric hernia repair not requiring mesh

Previous ipsilateral minimally invasive inguinal hernia repair (laparoscopic or robotic)

Previous radical prostatectomy procedure or pelvic irradiation

Trial design

Treatments tested in this trial

  • OTTAVA Robotic System

Treatment groups

30 Participants
are divided into 1 treatment group

Sponsors and collaborators